Table 4.
Characteristics | EQ-5D-3L | 95% CI | P-value | EQ-VAS | 95% CI | P-value |
---|---|---|---|---|---|---|
Mean ± SD | Mean ± SD | |||||
Genderb | < 0.001 | < 0.001 | ||||
Male | 0.41 ± 0.44 | 0.37–0.45 | 68.90 ± 16.78 | 67.24–70.57 | ||
Female | 0.29 ± 0.32 | 0.25–0.35 | 58.73 ± 15.99 | 56.43–61.02 | ||
Trans gender | 0.81 ± 0.03 | 0.80–0.83 | 83.50 ± 4.89 | 81.20–85.79 | ||
Ageb | < 0.001 | < 0.001 | ||||
18–25 years | 0.63 ± 0.32 | 0.58–0.68 | 78.40 ± 14.38 | 76.13–80.67 | ||
26–50 years | 0.52 ± 0.33 | 0.48–0.56 | 67.61 ± 17.11 | 65.46–69.75 | ||
> 50 years | 0.03 ± 0.32 | −0.01–0.07 | 54.74 ± 11.06 | 53.19–56.29 | ||
Marital statusb | < 0.001 | < 0.001 | ||||
Single | 0.57 ± 0.39 | 0.52–0.62 | 75.06 ± 14.81 | 73.19–76.93 | ||
Married/relationship | 0.39 ± 0.35 | 0.33–0.44 | 64.30 ± 17.71 | 61.52–67.08 | ||
Divorced/separated | 0.20 ± 0.38 | 0.14–0.26 | 59.14 ± 15.49 | 56.74–61.53 | ||
Widowed | 0.19 ± 0.39 | 0.09–0.30 | 55.74 ± 14.74 | 51.71–59.76 | ||
Level of educationb | < 0.001 | < 0.001 | ||||
Illiterate | 0.29 ± 0.51 | 0.21–0.36 | 62.25 ± 16.91 | 59.71–64.79 | ||
Primary | 0.36 ± 0.33 | 0.32–0.40 | 61.89 ± 15.49 | 59.86–63.92 | ||
Secondary | 0.39 ± 0.32 | 0.34–0.44 | 69.14 ± 13.44 | 67.07–71.22 | ||
Tertiary | 0.48 ± 0.29 | 0.41–0.55 | 97.15 ± 4.59 | 95.59–98.61 | ||
Employment statusa | < 0.001 | < 0.001 | ||||
Employed | 0.55 ± 0.37 | 0.49–0.59 | 72.34 ± 16.69 | 70.06–74.62 | ||
Non-employed | 0.30 ± 0.41 | 0.26–0.34 | 62.92 ± 16.62 | 61.27–64.57 | ||
Since HIV diagnosed (years)b | < 0.001 | < 0.001 | ||||
< 1 | 0.57 ± 0.39 | 0.52–0.62 | 74.47 ± 15.99 | 72.12–76.82 | ||
1–5 | 0.39 ± 0.35 | 0.33–0.43 | 62.91 ± 15.90 | 60.87–69.94 | ||
6–10 | 0.20 ± 0.38 | 0.14–0.26 | 58.25 ± 13.69 | 55.77–60.72 | ||
> 10 | 0.19 ± 0.39 | 0.08–0.31 | 69.84 ± 20.62 | 64.68–75.00 | ||
HIV serostatusb | < 0.001 | < 0.001 | ||||
Asymptomatic | 0.58 ± 0.37 | 0.53–0.62 | 74.75 ± 15.27 | 72.99–76.52 | ||
Symptomatic | 0.26 ± 0.34 | 0.22–0.29 | 59.15 ± 15.02 | 57.41–60.87 | ||
AIDS converted | −0.38 ± 0.22 | −0.48–0.28 | 45.10 ± 5.12 | 42.59–47.40 | ||
CD4 countb | < 0.001 | < 0.001 | ||||
< 200 | 0.03 ± 0.30 | −0.09–0.07 | 52.21 ± 9.83 | 50.80–53.61 | ||
200–500 | 0.34 ± 0.26 | 0.31–0.37 | 62.13 ± 12.06 | 60.58–63.69 | ||
> 500 | 0.83 ± 0.22 | 0.79–0.87 | 86.46 ± 8.25 | 85.23–87.68 | ||
Viral loada | < 0.001 | < 0.001 | ||||
Detectable | 0.22 ± 0.34 | 0.18–0.26 | 58.07 ± 12.77 | 56.60–59.54 | ||
Non-detectable | 0.55 ± 0.41 | 0.50–0.59 | 73.79 ± 17.40 | 71.85–75.73 | ||
Time on ARTb | < 0.001 | < 0.001 | ||||
< 12 months | 0.50 ± 0.35 | 0.45–0.55 | 72.97 ± 14.15 | 71.11–74.83 | ||
12–48 months | 0.56 ± 0.32 | 0.51–0.62 | 66.64 ± 18.09 | 63.61–69.66 | ||
> 48 months | 0.18 ± 0.41 | 0.13–0.23 | 59.49 ± 16.84 | 57.33–61.64 | ||
How you get infected with HIV?b | < 0.001 | < 0.001 | ||||
No idea | 0.12 ± 0.17 | 0.09–0.17 | 55.35 ± 16.49 | 51.15–59.55 | ||
Blood products | 0.30 ± 0.46 | 0.21–0.39 | 69.01 ± 14.63 | 66.35–71.64 | ||
Injecting drugs | 0.40 ± 0.41 | 0.3–0.44 | 66.45 ± 16.42 | 64.81–68.09 | ||
Sex with women | 0.34 ± 0.31 | 0.26–0.43 | 57.40 ± 14.11 | 53.38–61.41 | ||
Sex with men | 0.69 ± 0.32 | 0.58–0.81 | 68.18 ± 32.15 | 56.77–79.58 |
Bold values show a statistically significant difference
EQ EuroQoL, SD Standard deviation, CI Confidence interval
aIndependent samples t-test
bOne-Way ANOVA was applied to calculate p-value